Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine | Zendy

Marty Hinz | Zendy; Alvin Stein | Zendy; Thomas Uncini | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine

Author(s) -

Marty Hinz,

Alvin Stein,

Thomas Uncini

Publication year - 2011

Publication title -

open access journal of urology

Language(s) - English

Resource type - Journals

ISSN - 1179-1551

DOI - 10.2147/oaju.s16637

Subject(s) - norepinephrine , epinephrine , neurotransmitter , urinary system , medicine , baseline (sea) , endocrinology , neuroscience , dopamine , psychology , biology , central nervous system , fishery

The purpose of this paper is to present the results of statistical analysis of spot baseline urinary norepinephrine and epinephrine assays in correlation with spot baseline urinary serotonin and dopamine findings previously published by the authors. Our research indicates a need for physicians and decision-makers to understand the lack of validity of this type of spot baseline monoamine testing when using it in the decision-making process for neurotransmitter deficiency disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research